دورية أكاديمية
أعرض في EDS

Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson's disease.

التفاصيل البيبلوغرافية
العنوان: Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson's disease.
المؤلفون: Soares NM; Universidade Federal de Ciências da Saúde de Porto Alegre, UFCSPA, Porto Alegre, RS, Brazil. nayronn@gmail.com.; Universidade Federal do Rio Grande do Sul, UFRGS, Porto Alegre, RS, Brazil. nayronn@gmail.com.; Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, HCPA, Porto Alegre, RS, Brazil. nayronn@gmail.com., da Silva PHR; Serviço Interdisciplinar de Neuromodulação do Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, USP, São Paulo, SP, Brazil., Pereira GM; Universidade Federal de Ciências da Saúde de Porto Alegre, UFCSPA, Porto Alegre, RS, Brazil.; Universidade Federal do Rio Grande do Sul, UFRGS, Porto Alegre, RS, Brazil.; Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, HCPA, Porto Alegre, RS, Brazil., Leoni RF; Faculdade de Filosofia Ciências e Letras de Ribeirão Preto da Universidade de São Paulo, USP, Ribeirao Preto, SP, Brazil., Rieder CRM; Departamento de Clínica Médica, Universidade Federal de Ciências da Saúde de Porto Alegre, UFCSPA, Porto Alegre, RS, Brazil.; Serviço de Neurologia, Irmandade Santa Casa de Misericórdia de Porto Alegre, ISCMPA, Porto Alegre, RS, Brazil., Alva TAP; Departamento de Ciências Exatas e Sociais Aplicadas, Universidade Federal de Ciências da Saúde de Porto Alegre, UFCSPA, Porto Alegre, RS, Brazil.
المصدر: Neuroradiology [Neuroradiology] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.
Publication Model: Ahead of Print
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 1302751 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1920 (Electronic) Linking ISSN: 00283940 NLM ISO Abbreviation: Neuroradiology Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Berlin, New York, Springer-Verlag.
مستخلص: Introduction: Parkinson's disease (PD) is a neurodegenerative disorder characterized by dopaminergic neurons' degeneration of the substantia nigra, presenting with motor and non-motor symptoms. We hypothesized that altered diffusion metrics are associated with clinical symptoms in de novo PD patients.
Methods: Fractional Anisotropy (FA) and Mean (MD), Axial (AD), and Radial Diffusivity (RD) were assessed in 55 de novo PD patients (58.62 ± 9.85 years, 37 men) and 55 age-matched healthy controls (59.92 ± 11.25 years, 34 men). Diffusion-weighted images and clinical variables were collected from the Parkinson's Progression Markers Initiative study. Tract-based spatial statistics were used to identify white matter (WM) changes, and fiber tracts were localized using the JHU-WM tractography atlas. Motor and non-motor symptoms were evaluated in patients.
Results: We observed higher FA values and lower RD values in patients than controls in various fiber tracts (p-TFCE < 0.05). No significant MD or AD difference was observed between groups. Diffusion metrics of several regions significantly correlated with non-motor (state and trait anxiety and daytime sleepiness) and axial motor symptoms in the de novo PD group. No correlations were observed between diffusion metrics and other clinical symptoms evaluated.
Conclusion: Our findings suggest microstructural changes in de novo PD fiber tracts; however, limited associations with clinical symptoms reveal the complexity of PD pathology. They may contribute to understanding the neurobiological changes underlying PD and have implications for developing targeted interventions. However, further longitudinal research with larger cohorts and consideration of confounding factors are necessary to elucidate the underlying mechanisms of these diffusion alterations in de novo PD.
(© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
References: de Lau LML, Breteler MMB (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535. (PMID: 1671392410.1016/S1474-4422(06)70471-9)
Thenganatt MA, Jankovic J (2014) Parkinson disease subtypes. JAMA Neurol 71:499–504. (PMID: 2451486310.1001/jamaneurol.2013.6233)
Pringsheim T, Jette N, Frolkis A, Steeves TDL (2014) The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1583–1590. (PMID: 2497610310.1002/mds.25945)
Hayes MT (2019) Parkinson’s disease and parkinsonism. Am J Med 132:802–807. (PMID: 3089042510.1016/j.amjmed.2019.03.001)
Massano J, Bhatia KP (2012) Clinical approach to Parkinson’s disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2:a008870. (PMID: 22675666336753510.1101/cshperspect.a008870)
Herrero M-T, Estrada C, Maatouk L, Vyas S (2015) Inflammation in Parkinson’s disease: role of glucocorticoids. Front Neuroanat 9:32. (PMID: 25883554438297210.3389/fnana.2015.00032)
Jankovic J (2008) Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368–376. (PMID: 1834439210.1136/jnnp.2007.131045)
DeMaagd G, Philip A (2015) Parkinson’s Disease and its management: part 1: Disease Entity, Risk factors, pathophysiology, clinical presentation, and diagnosis. P T 40:504–532. (PMID: 262361394517533)
Rana AQ, Ahmed US, Chaudry ZM, Vasan S (2015) Parkinson’s disease: a review of non-motor symptoms. Expert Rev Neurother 15:549–562. (PMID: 2593684710.1586/14737175.2015.1038244)
Lee HM, Koh S-B (2015) Many faces of Parkinson’s Disease: non-motor symptoms of Parkinson’s Disease. J Mov Disord 8:92–97. (PMID: 26090081446054510.14802/jmd.15003)
Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. (PMID: 2833248810.1038/nrdp.2017.13)
Aarsland D, Creese B, Politis M et al (2017) Cognitive decline in Parkinson disease. Nat Rev Neurol 13:217–231. (PMID: 28257128564302710.1038/nrneurol.2017.27)
Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27:27–42. (PMID: 3163145510.1111/ene.14108)
Tibar H, El Bayad K, Bouhouche A et al (2018) Non-motor symptoms of Parkinson’s Disease and their impact on quality of life in a cohort of Moroccan patients. Front Neurol 9:170. (PMID: 29670566589386610.3389/fneur.2018.00170)
Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211. (PMID: 1249895410.1016/S0197-4580(02)00065-9)
Ferreira N, Richner M, van der Laan A et al (2021) Prodromal neuroinvasion of pathological α-synuclein in brainstem reticular nuclei and white matter lesions in a model of α-synucleinopathy. Brain Commun 3:fcab104. (PMID: 34136810820214610.1093/braincomms/fcab104)
Taylor KI, Sambataro F, Boess F et al (2018) Progressive decline in Gray and White Matter Integrity in de novo Parkinson’s Disease: an analysis of longitudinal Parkinson progression markers Initiative Diffusion Tensor Imaging Data. Front Aging Neurosci 10:318. (PMID: 30349475618695610.3389/fnagi.2018.00318)
Shih Y-C, Tseng W-YI, Montaser-Kouhsari L (2022) Recent advances in using diffusion tensor imaging to study white matter alterations in Parkinson’s disease: a mini review. Front Aging Neurosci 14:1018017. (PMID: 3691086110.3389/fnagi.2022.1018017)
Basser PJ, Mattiello J, LeBihan D (1994) MR diffusion tensor spectroscopy and imaging. Biophys J 66:259–267. (PMID: 8130344127568610.1016/S0006-3495(94)80775-1)
Jiang Y, An H, Xi Q et al (2022) Diffusion Tensor Imaging reveals deep brain structure changes in early Parkinson’s Disease patients with various Sleep disorders. Brain Sci 12. https://doi.org/10.3390/brainsci12040463.
Shih Y-C, Ooi LQR, Li H-H et al (2023) Serial deep gray nuclear DTI changes in Parkinson’s disease over twelve years. Front Aging Neurosci 15:1169254. (PMID: 374090081031817310.3389/fnagi.2023.1169254)
Sanjari Moghaddam H, Dolatshahi M, Mohebi F, Aarabi MH (2020) Structural white matter alterations as compensatory mechanisms in Parkinson’s disease: a systematic review of diffusion tensor imaging studies. J Neurosci Res 98:1398–1416. (PMID: 3233342610.1002/jnr.24617)
Zhang Y, Burock MA (2020) Diffusion Tensor Imaging in Parkinson’s Disease and Parkinsonian Syndrome: a systematic review. Front Neurol 11:531993. (PMID: 33101169754627110.3389/fneur.2020.531993)
Prasuhn J, Heldmann M, Münte TF, Brüggemann N (2020) A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasets. Neurol Res Pract 2:46. (PMID: 33324945765403410.1186/s42466-020-00092-y)
Hall DA, Moore C, Comella C, SPARX Study Group (2018) Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial. Trials 19:630. (PMID: 30428907623704210.1186/s13063-018-2958-z)
Marek K, Jennings D, Lasch S et al (2011) The Parkinson progression marker Initiative (PPMI). Prog Neurobiol 95:629–635. (PMID: 901472510.1016/j.pneurobio.2011.09.005)
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184. (PMID: 1564476101472010.1136/jnnp.55.3.181)
Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312. (PMID: 1539000710.1002/mds.20153)
Stiasny-Kolster K, Mayer G, Schäfer S et al (2007) The REM sleep behavior disorder screening questionnaire–a new diagnostic instrument. Mov Disord 22:2386–2393. (PMID: 1789433710.1002/mds.21740)
Buysse DJ, Reynolds CF 3rd, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213. (PMID: 274877110.1016/0165-1781(89)90047-4)
Spielberger CD (1989) State-trait anxiety inventory: bibliography, 2nd edn. Palo Alto.
Sheikh JI, Yesavage JA (1986) Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontologist: J Aging Mental Health 5:165–173. (PMID: 10.1300/J018v05n01_09)
Weintraub D, Saboe K, Stern MB (2007) Effect of age on geriatric depression scale performance in Parkinson’s disease. Mov Disord 22:1331–1335. (PMID: 17546674200079810.1002/mds.21369)
Weintraub D, Oehlberg KA, Katz IR, Stern MB (2006) Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry 14:169–175. (PMID: 16473982157104610.1097/01.JGP.0000192488.66049.4b)
Goetz CG, Tilley BC, Shaftman SR et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23:2129–2170. (PMID: 1902598410.1002/mds.22340)
Li X, Xing Y, Martin-Bastida A et al (2018) Patterns of grey matter loss associated with motor subscores in early Parkinson’s disease. Neuroimage Clin 17:498–504. (PMID: 2920163810.1016/j.nicl.2017.11.009)
Ashraf-Ganjouei A, Majd A, Javinani A, Aarabi MH (2018) Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson’s disease. PeerJ 6:e5539. (PMID: 30225168613924110.7717/peerj.5539)
Vichianin Y, Kareesaw A, Chawalparit O, Ohki M (2018) Optimizing fractional intensity threshold for FSLBrain extraction Tool (BET) and comparing with FreeSurfer on 3D T1W MR images. Siriraj Med J 70:391–396.
Kong Y, Wang D, Shi L et al (2014) Adaptive distance metric learning for diffusion tensor image segmentation. PLoS ONE 9:e92069. (PMID: 24651858396129610.1371/journal.pone.0092069)
Kotian RP, Koteshwar P (2022) Fractional anisotropy: Scalar Derivative of Diffusion-Tensor Imaging. In: Kotian RP, Koteshwar P (eds) Diffusion Tensor Imaging and Fractional Anisotropy: imaging biomarkers in early Parkinson’s Disease. Springer Nature Singapore, Singapore, pp 59–84. (PMID: 10.1007/978-981-19-5001-8_5)
Winkler AM, Ridgway GR, Webster MA et al (2014) Permutation inference for the general linear model. NeuroImage 92:381–397. (PMID: 2453083910.1016/j.neuroimage.2014.01.060)
Hua K, Zhang J, Wakana S et al (2008) Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. NeuroImage 39:336–347. (PMID: 1793189010.1016/j.neuroimage.2007.07.053)
Kotian RP, Prakashini K, Nair NS (2020) A Diffusion tensor imaging study to compare normative fractional anisotropy values with patients suffering from Parkinson’s disease in the brain grey and white matter. bioRxiv.
Gattellaro G, Minati L, Grisoli M et al (2009) White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 30:1222–1226. (PMID: 19342541705133810.3174/ajnr.A1556)
Zhan W, Kang GA, Glass GA et al (2012) Regional alterations of brain microstructure in Parkinson’s disease using diffusion tensor imaging. Mov Disord 27:90–97. (PMID: 2185066810.1002/mds.23917)
Langley J, Huddleston DE, Merritt M et al (2016) Diffusion tensor imaging of the substantia nigra in Parkinson’s disease revisited. Hum Brain Mapp 37:2547–2556. (PMID: 27029026490578410.1002/hbm.23192)
Duncan GW, Firbank MJ, Yarnall AJ et al (2016) Gray and white matter imaging: a biomarker for cognitive impairment in early Parkinson’s disease? Mov Disord 31:103–110. (PMID: 2620280210.1002/mds.26312)
Chen N-K, Chou Y-H, Sundman M et al (2018) Alteration of Diffusion-Tensor Magnetic Resonance Imaging Measures in brain regions involved in early stages of Parkinson’s Disease. Brain Connect 8:343–349. (PMID: 29877094610324510.1089/brain.2017.0558)
Tessa C, Giannelli M, Della Nave R et al (2008) A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol 29:674–680. (PMID: 18184843797817710.3174/ajnr.A0900)
Zhang Y, Wu I-W, Tosun D et al (2016) Progression of Regional Microstructural Degeneration in Parkinson’s Disease: a Multicenter Diffusion Tensor Imaging Study. PLoS ONE 11:e0165540. (PMID: 27798653508790010.1371/journal.pone.0165540)
Atkinson-Clement C, Pinto S, Eusebio A, Coulon O (2017) Diffusion tensor imaging in Parkinson’s disease: review and meta-analysis. Neuroimage Clin 16:98–110. (PMID: 28765809552715610.1016/j.nicl.2017.07.011)
Wen M-C, Heng HSE, Ng SYE et al (2016) White matter microstructural characteristics in newly diagnosed Parkinson’s disease: an unbiased whole-brain study. Sci Rep 6:35601. (PMID: 27762307507185910.1038/srep35601)
Pelizzari L, Di Tella S, Laganà MM et al (2020) White matter alterations in early Parkinson’s disease: role of motor symptom lateralization. Neurol Sci 41:357–364. (PMID: 3165043810.1007/s10072-019-04084-y)
Broen MPG, Narayen NE, Kuijf ML et al (2016) Prevalence of anxiety in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 31:1125–1133. (PMID: 2712596310.1002/mds.26643)
Khedr EM, Abdelrahman AA, Elserogy Y et al (2020) Depression and anxiety among patients with Parkinson’s disease: frequency, risk factors, and impact on quality of life. Egypt J Neurol Psychiatry Neurosurg 56:1–9.
Witjas T, Kaphan E, Azulay JP et al (2002) Nonmotor fluctuations in Parkinson’s disease: frequent and disabling. Neurology 59:408–413. (PMID: 1217737510.1212/WNL.59.3.408)
Carey G, Görmezoğlu M, de Jong JJA et al (2021) Neuroimaging of anxiety in Parkinson’s Disease: a systematic review. Mov Disord 36:327–339. (PMID: 3328919510.1002/mds.28404)
Gu L, Li J, Feng D-F et al (2013) Detection of white matter lesions in the acute stage of diffuse axonal injury predicts long-term cognitive impairments: a clinical diffusion tensor imaging study. J Trauma Acute Care Surg 74:242. (PMID: 2306461210.1097/TA.0b013e3182684fe8)
Winklewski PJ, Sabisz A, Naumczyk P et al (2018) Understanding the Physiopathology behind Axial and Radial Diffusivity Changes—what do we know? https://doi.org/10.3389/fneur.2018.00092 . Front Neurol 9.
Ataide M, Franco CMR, Lins OG (2014) Daytime sleepiness in Parkinson’s disease: perception, influence of drugs, and mood disorder. Sleep Disord 2014:939713. (PMID: 24587912392081910.1155/2014/939713)
Al-Qassabi A, Fereshtehnejad S-M, Postuma RB (2017) Sleep disturbances in the Prodromal Stage of Parkinson Disease. Curr Treat Options Neurol 19:22. (PMID: 2846642910.1007/s11940-017-0458-1)
Zhu K, van Hilten JJ, Marinus J (2016) Course and risk factors for excessive daytime sleepiness in Parkinson’s disease. Parkinsonism Relat Disord 24:34–40. (PMID: 2684660910.1016/j.parkreldis.2016.01.020)
Yaffe K, Nasrallah I, Hoang TD et al (2016) Sleep duration and White Matter Quality in Middle-aged adults. Sleep 39:1743–1747. (PMID: 27397561498926310.5665/sleep.6104)
Zeestraten EA, Benjamin P, Lambert C et al (2016) Application of Diffusion Tensor Imaging Parameters to detect change in Longitudinal studies in Cerebral Small Vessel Disease. PLoS ONE 11:e0147836. (PMID: 26808982472660410.1371/journal.pone.0147836)
Skidmore FM, Monroe WS, Hurt CP et al (2022) The emerging postural instability phenotype in idiopathic Parkinson disease. NPJ Parkinsons Dis 8:28. (PMID: 35304493893356110.1038/s41531-022-00287-x)
Nazmuddin M, van Dalen J-W, Borra RJH et al (2021) Postural and gait symptoms in de novo Parkinson’s disease patients correlate with cholinergic white matter pathology. Parkinsonism Relat Disord 93:43–49. (PMID: 3478452610.1016/j.parkreldis.2021.11.010)
Wilson J, Yarnall AJ, Craig CE et al (2021) Cholinergic basal forebrain volumes predict Gait decline in Parkinson’s Disease. Mov Disord 36:611–621. (PMID: 3338212610.1002/mds.28453)
Yust-Katz S, Tesler D, Treves TA et al (2008) Handedness as a predictor of side of onset of Parkinson’s disease. Parkinsonism Relat Disord 14:633–635. (PMID: 1834692610.1016/j.parkreldis.2008.01.017)
Orhan Varoğlu A, Aydin A (2021) An evaluation of right-sided Symptom Onset as a predictor of poor Parkinson’s Disease Prognosis. Cureus 13:e13493. (PMID: 336339217899409)
معلومات مُعتمدة: Michael J. Fox Foundation for Parkinson's Research Michael J. Fox Foundation for Parkinson's Research
فهرسة مساهمة: Keywords: Fractional anisotropy; Mean diffusivity; Motor symptoms; Non-motor symptoms; Parkinson’s disease; White matter
تواريخ الأحداث: Date Created: 20240827 Latest Revision: 20240827
رمز التحديث: 20240827
DOI: 10.1007/s00234-024-03452-6
PMID: 39190159
قاعدة البيانات: MEDLINE
الوصف
تدمد:1432-1920
DOI:10.1007/s00234-024-03452-6